4.8 Article

An enzyme-free electrochemiluminescence biosensor for ultrasensitive assay of Group B Streptococci based on self-enhanced luminol complex functionalized CuMn-CeO2 nanospheres

Journal

BIOSENSORS & BIOELECTRONICS
Volume 127, Issue -, Pages 167-173

Publisher

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2018.12.012

Keywords

CuMn-CeO2-PEI-luminol; Electrochemiluminescence; MNAzyme; Intramolecular co-reaction; Group B Streptococci

Funding

  1. Program for Innovation Team of Higher Education in Chongqing [CXTDX201601015]
  2. National Natural Science Foundation of China [81873980, 21804015]
  3. Natural Science Foundation Project of CQ CSTC [cstc2018jcyjAX0206]
  4. China Postdoctoral Science Foundation [2017M622979]
  5. Chongqing Postdoctoral Science Special Foundation [XmT2018073]
  6. Leading Talent Program of CQCSTC [CSTCCXLJRC201719]

Ask authors/readers for more resources

Herein, a novel and pragmatic electrochemiluminescence (ECL) biosensing method was developed for ultra sensitive and specific detection of Group B Streptococci (GBS) by combining self-enhanced luminol complex functionalized CuMn-CeO2 (CuMn-CeO2-PEI-luminol) with MNAzyme-mediated target-recycling amplification. First, the efficient self-enhanced PEI-luminol luminophore was prepared by combining PEI co-reactant with luminol in one molecular, which shortened electron transfer distance and enhanced ECL signal. And CuMn-CeO2 was applied to load a large number of PEI-luminol and strengthen luminous efficiency of luminol by the high catalytic activity toward H2O2 oxidation. Then, target-driven MNAzyme system was used to realize the circulation of GBS nucleic acid sequence, producing plentiful triggers to initiate the hybridization reaction on the surface of electrode. The developed enzyme-free ECL biosensor showed ultra-sensitivity for target DNA detection with detection limits of 68 aM (synthetic DNA) and 5 x 10(2) CFU mL(-1) (genomic DNA extracted from GBS strain). More importantly, this biosensor was successfully applied for detection of genomic DNA of GBS extracted from clinical vaginal/anal swabs as low as 320 copies. Thus, this proposed strategy might be an pragmatic ECL platform for ultrasensitive and specific detection of GBS in clinical vaginal/anal swabs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available